2FV.F Stock Analysis
2F
Uncovered
ScandiDos AB is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
ScandiDos AB engages in the provision of unique measurement systems and software for dosage and quality assurance within radiation therapy. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-11. The firm's competence includes the design and development of radiation detectors, electrometers and application software, as well as clinical experience in medical physics and radiation measurements. The firm's business focuses on developing such applications as Arc Therapy - IMAT/VMAT, Tomotherapy, IMRT and Machine QA, among others. ScandiDos AB markets its products under the Delta4 brand. Delta4 offers Delta4AT - At Treatment in-vivo dosimetry for advanced RT and Delta4PT - Pre Treatment volumetric plan QA, among others. The company operates in Europe, Asia, North America and Asia, and through numerous distributors and subsidiaries, including Additec GmbH and Conmedica GmbH in Germany, and ScandiDos SAS in France.